Status:
COMPLETED
Near Normalisation of BG Improves the Potentiating Effect of GLP-1
Lead Sponsor:
Hvidovre University Hospital
Conditions:
Diabetes Mellitus Type 2
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The ability of glucagon-like peptide 1 to enhance beta-cell responsiveness to I.v. glucose is impaired in patients with type 2 diabetes mellitus compared with healthy individuals. We investigated whet...
Eligibility Criteria
Inclusion
- Age 18-70 years
- Type 2 diabetes diagnosed after 30 years of age
- BMI \> 25
Exclusion
- Severe complications to diabetes
- Abnormal liver og kidney function
- Haemoglobin below the lower limit
- Macroalbuminuria
- Systemic disease
- Pregnancy
Key Trial Info
Start Date :
February 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2004
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT00612625
Start Date
February 1 2004
End Date
December 1 2004
Last Update
February 12 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Endocrinology, Hvidovre Hospital
Copenhagen, Denmark